ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
114 hedge funds and large institutions have $728M invested in Endocyte, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+25
Holders Change %
+28.09%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
54
Increased
18
Reduced
24
Closed
28
Calls
$4.41M
Puts
$6.12M
Net Calls
-$1.71M
Net Calls Change
-$3.44M
Top Buyers
| 1 |
BlackRock
New York
|
$71.9M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$78M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$27.6M |
| 4 |
State Street
Boston,
Massachusetts
|
$21.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
$13.6M |
